Imiquimod (Aldara(TM) cream)

Infectious Diseases in Obstetrics and Gynecology

Volumn 6, Issue 2, 1998, Pages 49-51

  Buck, H W ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Anogenital warts; Human papillomavirus; Immune response modifier

Indexed keywords

CYTOKINE; IMIQUIMOD; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONDYLOMA; CONFERENCE PAPER; DRUG ABSORPTION; DRUG COST; DRUG EXCRETION; DRUG MECHANISM; DRUG STRUCTURE; ELECTROSURGERY; HUMAN; LASER SURGERY; NONHUMAN; PAIN; PRIORITY JOURNAL; PRURITUS; TOPICAL DRUG ADMINISTRATION; CONDYLOMA ACUMINATUM; DRUG INTERACTION; FEMALE; MALE; REVIEW;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; DRUG INTERACTIONS; FEMALE; HUMANS; MALE;

EID: 0031596009     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-0997(1998)6:2<49::AID-IDOG3>3.0.CO;2-2     Document Type: Conference Paper

References (11)

1. Full prescribing information for Aldara™ (imiquimod), 3M Pharmaceutical, St. Paul, MN, March 1997.
2. Testerman TL, Gerster JF, Imbertson LM, et al.: Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 58:365-372, 1995.
3. Tyring SK, Arany I, Stanley MA, et al.: A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998, in press.
4. Bernstein DI, Harrison CJ: Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother 33:1511-1515, 1989.
5. Bernstein DI, Harrison CJ, Tepe ER, Shahwan A, Miller RL: Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs. Vaccine 13:72-76, 1995.
6. Bernstein DI, Miller RL, Harrison CJ: Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea pigs when begun after lesion development. Antiviral Res 20:45-55, 1993.
7. Harrison CJ, Miller RL, Bernstein DI: Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother 38:2059-2064, 1994.
8. Chen M, Griffith BP, Lucia HL, Hsiung GD: Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother 32:678-683, 1988.
9. Kende M, Lupton HW, Canonico PG: Treatment of experimental viral infections with immunomodulators. Adv Biosci 68:51-63, 1989.
10. Centers for Disease Control and Prevention: 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 47(No. RR-1):88-95, 1998.
11. Edwards L, Ferenczy A, Eron L, et al.: Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 134:25-30, 1998.